Valeria Caso, MD, PhD
Professor of Neurology
University of Perugia
Perugia, Italy
Manesh R. Patel, MD
Richard S. Stack Distinguished Professor
Chief, Division of Cardiology
Co-Director Duke Heart Center
Duke Clinical Research Institute
Duke University
Durham, NC
Mike Sharma, MD, MSc, FRCPC
Director, Stroke Program
Michael G. Degroote Chair in Stroke Prevention
McMaster University
Population Health Research Institute
Hamilton, ON, Canada
Ashkan Shoamanesh, MD, PhD
Founding Director, Hemorrhagic Stroke Research Program and Scientist
Population Health Research Institute
Director, Stroke Fellowship Program
Hamilton Health Sciences
McMaster University
Hamilton, ON, Canada
5:30pm
–
Registration & Dinner
6:00pm
–
Welcome and Introduction
–
Preventing and Managing Acute Ischemic Stroke/TIA in Today’s World – Dr. Sharma
–
While Antiplatelets Are Good…They Aren’t for Everyone – Dr. Caso
–
The Path Forward: What’s On the Horizon? – Dr. Patel
–
Emerging Data in the Management of Acute Ischemic Stroke/TIA – Dr. Shoamanesh
Target Audience
This activity has been designed to meet the educational needs of the interprofessional team, which includes neurologists and cardiologists, as well as other healthcare providers involved in the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA.
Learning Objectives
After completing this activity, the participant should be better able to:
- Review the currently available therapeutics and how they affect multiple pathways involved in the coagulation cascade, thereby increasing the potential for serious bleeds
- Discuss factor XI and factor XIa inhibition and review new and emerging anticoagulation pharmacotherapy for secondary stroke prevention